Human papillomavirus testing for triage of women with low-grade squamous intraepithelial lesions

Jack Cuzick, J. Thomas Cox, Guili Zhang, Mark H. Einstein, Mark Stoler, Suzanne Trupin, Catherine M. Behrens

Research output: Contribution to journalArticle

18 Citations (Scopus)

Abstract

Low-grade squamous intraepithelial lesion (LSIL) is a common cytologic finding in cervical screening, yet only about 10-20% have significant histologic abnormalities and these are almost always positive for high-risk human papillomavirus (hrHPV). This analysis aims to clarify the role of hrHPV DNA testing in the triage of women with LSIL cytology. In the ATHENA screening trial, we examined 1,084 cases of LSIL, of which 925 had an evaluable biopsy, to determine the extent to which hrHPV testing can identify those patients who have precursor lesions in need of immediate clinical referral and those who have changes more likely to regress spontaneously. Overall, 71.2% of LSIL cases were hrHPV positive, but the prevalence was age dependent, with only 56.1% in women ≥40 years. Among women with LSIL, 11.6% (107/925) had a cervical intraepithelial neoplasia grade 2 or worse (CIN2+) histologic diagnosis and, of these, only nine were hrHPV negative. For CIN3+, 91.7% (44/48) of women with LSIL were hrHPV positive. The negative predictive value of hrHPV testing for CIN3+ in LSIL was 100% for women aged ≥40 years. Women who were HPV16 positive had a higher positive predictive value for CIN2+ (25.4%) than those who were positive for 12 other pooled hrHPV types (11.5%). Testing for hrHPV in women with LSIL is effective in identifying high-grade cervical lesions, thereby avoiding unnecessary referrals to colposcopy and potential over-treatment of non-progressive lesions, especially for women aged ≥40 years.

Original languageEnglish (US)
Pages (from-to)959-966
Number of pages8
JournalInternational Journal of Cancer
Volume132
Issue number4
DOIs
StatePublished - Feb 15 2012

Fingerprint

Triage
Referral and Consultation
Squamous Intraepithelial Lesions of the Cervix
Colposcopy
Cervical Intraepithelial Neoplasia
Cell Biology
Biopsy
DNA

Keywords

  • ATHENA
  • human papillomavirus
  • LSIL

ASJC Scopus subject areas

  • Cancer Research
  • Oncology

Cite this

Cuzick, J., Thomas Cox, J., Zhang, G., Einstein, M. H., Stoler, M., Trupin, S., & Behrens, C. M. (2012). Human papillomavirus testing for triage of women with low-grade squamous intraepithelial lesions. International Journal of Cancer, 132(4), 959-966. https://doi.org/10.1002/ijc.27723

Human papillomavirus testing for triage of women with low-grade squamous intraepithelial lesions. / Cuzick, Jack; Thomas Cox, J.; Zhang, Guili; Einstein, Mark H.; Stoler, Mark; Trupin, Suzanne; Behrens, Catherine M.

In: International Journal of Cancer, Vol. 132, No. 4, 15.02.2012, p. 959-966.

Research output: Contribution to journalArticle

Cuzick, J, Thomas Cox, J, Zhang, G, Einstein, MH, Stoler, M, Trupin, S & Behrens, CM 2012, 'Human papillomavirus testing for triage of women with low-grade squamous intraepithelial lesions', International Journal of Cancer, vol. 132, no. 4, pp. 959-966. https://doi.org/10.1002/ijc.27723
Cuzick, Jack ; Thomas Cox, J. ; Zhang, Guili ; Einstein, Mark H. ; Stoler, Mark ; Trupin, Suzanne ; Behrens, Catherine M. / Human papillomavirus testing for triage of women with low-grade squamous intraepithelial lesions. In: International Journal of Cancer. 2012 ; Vol. 132, No. 4. pp. 959-966.
@article{94c078ed0af644d4b03227427568d03b,
title = "Human papillomavirus testing for triage of women with low-grade squamous intraepithelial lesions",
abstract = "Low-grade squamous intraepithelial lesion (LSIL) is a common cytologic finding in cervical screening, yet only about 10-20{\%} have significant histologic abnormalities and these are almost always positive for high-risk human papillomavirus (hrHPV). This analysis aims to clarify the role of hrHPV DNA testing in the triage of women with LSIL cytology. In the ATHENA screening trial, we examined 1,084 cases of LSIL, of which 925 had an evaluable biopsy, to determine the extent to which hrHPV testing can identify those patients who have precursor lesions in need of immediate clinical referral and those who have changes more likely to regress spontaneously. Overall, 71.2{\%} of LSIL cases were hrHPV positive, but the prevalence was age dependent, with only 56.1{\%} in women ≥40 years. Among women with LSIL, 11.6{\%} (107/925) had a cervical intraepithelial neoplasia grade 2 or worse (CIN2+) histologic diagnosis and, of these, only nine were hrHPV negative. For CIN3+, 91.7{\%} (44/48) of women with LSIL were hrHPV positive. The negative predictive value of hrHPV testing for CIN3+ in LSIL was 100{\%} for women aged ≥40 years. Women who were HPV16 positive had a higher positive predictive value for CIN2+ (25.4{\%}) than those who were positive for 12 other pooled hrHPV types (11.5{\%}). Testing for hrHPV in women with LSIL is effective in identifying high-grade cervical lesions, thereby avoiding unnecessary referrals to colposcopy and potential over-treatment of non-progressive lesions, especially for women aged ≥40 years.",
keywords = "ATHENA, human papillomavirus, LSIL",
author = "Jack Cuzick and {Thomas Cox}, J. and Guili Zhang and Einstein, {Mark H.} and Mark Stoler and Suzanne Trupin and Behrens, {Catherine M.}",
year = "2012",
month = "2",
day = "15",
doi = "10.1002/ijc.27723",
language = "English (US)",
volume = "132",
pages = "959--966",
journal = "International Journal of Cancer",
issn = "0020-7136",
publisher = "Wiley-Liss Inc.",
number = "4",

}

TY - JOUR

T1 - Human papillomavirus testing for triage of women with low-grade squamous intraepithelial lesions

AU - Cuzick, Jack

AU - Thomas Cox, J.

AU - Zhang, Guili

AU - Einstein, Mark H.

AU - Stoler, Mark

AU - Trupin, Suzanne

AU - Behrens, Catherine M.

PY - 2012/2/15

Y1 - 2012/2/15

N2 - Low-grade squamous intraepithelial lesion (LSIL) is a common cytologic finding in cervical screening, yet only about 10-20% have significant histologic abnormalities and these are almost always positive for high-risk human papillomavirus (hrHPV). This analysis aims to clarify the role of hrHPV DNA testing in the triage of women with LSIL cytology. In the ATHENA screening trial, we examined 1,084 cases of LSIL, of which 925 had an evaluable biopsy, to determine the extent to which hrHPV testing can identify those patients who have precursor lesions in need of immediate clinical referral and those who have changes more likely to regress spontaneously. Overall, 71.2% of LSIL cases were hrHPV positive, but the prevalence was age dependent, with only 56.1% in women ≥40 years. Among women with LSIL, 11.6% (107/925) had a cervical intraepithelial neoplasia grade 2 or worse (CIN2+) histologic diagnosis and, of these, only nine were hrHPV negative. For CIN3+, 91.7% (44/48) of women with LSIL were hrHPV positive. The negative predictive value of hrHPV testing for CIN3+ in LSIL was 100% for women aged ≥40 years. Women who were HPV16 positive had a higher positive predictive value for CIN2+ (25.4%) than those who were positive for 12 other pooled hrHPV types (11.5%). Testing for hrHPV in women with LSIL is effective in identifying high-grade cervical lesions, thereby avoiding unnecessary referrals to colposcopy and potential over-treatment of non-progressive lesions, especially for women aged ≥40 years.

AB - Low-grade squamous intraepithelial lesion (LSIL) is a common cytologic finding in cervical screening, yet only about 10-20% have significant histologic abnormalities and these are almost always positive for high-risk human papillomavirus (hrHPV). This analysis aims to clarify the role of hrHPV DNA testing in the triage of women with LSIL cytology. In the ATHENA screening trial, we examined 1,084 cases of LSIL, of which 925 had an evaluable biopsy, to determine the extent to which hrHPV testing can identify those patients who have precursor lesions in need of immediate clinical referral and those who have changes more likely to regress spontaneously. Overall, 71.2% of LSIL cases were hrHPV positive, but the prevalence was age dependent, with only 56.1% in women ≥40 years. Among women with LSIL, 11.6% (107/925) had a cervical intraepithelial neoplasia grade 2 or worse (CIN2+) histologic diagnosis and, of these, only nine were hrHPV negative. For CIN3+, 91.7% (44/48) of women with LSIL were hrHPV positive. The negative predictive value of hrHPV testing for CIN3+ in LSIL was 100% for women aged ≥40 years. Women who were HPV16 positive had a higher positive predictive value for CIN2+ (25.4%) than those who were positive for 12 other pooled hrHPV types (11.5%). Testing for hrHPV in women with LSIL is effective in identifying high-grade cervical lesions, thereby avoiding unnecessary referrals to colposcopy and potential over-treatment of non-progressive lesions, especially for women aged ≥40 years.

KW - ATHENA

KW - human papillomavirus

KW - LSIL

UR - http://www.scopus.com/inward/record.url?scp=84871376636&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84871376636&partnerID=8YFLogxK

U2 - 10.1002/ijc.27723

DO - 10.1002/ijc.27723

M3 - Article

VL - 132

SP - 959

EP - 966

JO - International Journal of Cancer

JF - International Journal of Cancer

SN - 0020-7136

IS - 4

ER -